188 related articles for article (PubMed ID: 21452193)
1. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer.
Jonnalagadda S; Arcinega J; Smith C; Wisnivesky JP
Cancer; 2011 Oct; 117(20):4724-31. PubMed ID: 21452193
[TBL] [Abstract][Full Text] [Related]
2. Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer.
Wisnivesky JP; Arciniega J; Mhango G; Mandeli J; Halm EA
Thorax; 2011 Apr; 66(4):287-93. PubMed ID: 21131298
[TBL] [Abstract][Full Text] [Related]
3. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.
Deng W; Xu T; Wang Y; Xu Y; Yang P; Gomez D; Liao Z
Lung Cancer; 2018 Aug; 122():60-66. PubMed ID: 30032846
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
5. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
6. The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer.
Jonnalagadda S; Smith C; Mhango G; Wisnivesky JP
Chest; 2011 Aug; 140(2):433-440. PubMed ID: 21292754
[TBL] [Abstract][Full Text] [Related]
7. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
8. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
[TBL] [Abstract][Full Text] [Related]
9. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
Zhou X; Wu C; Cheng Q
Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
[TBL] [Abstract][Full Text] [Related]
10. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
[TBL] [Abstract][Full Text] [Related]
12. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
13. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.
Ding X; Hui Z; Dai H; Fan C; Men Y; Ji W; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Lu N; He J; Wang L
J Thorac Oncol; 2016 Sep; 11(9):1565-73. PubMed ID: 27223457
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
Tran TB; Qadan M; Dua MM; Norton JA; Poultsides GA; Visser BC
Surgery; 2015 Aug; 158(2):486-93. PubMed ID: 26013988
[TBL] [Abstract][Full Text] [Related]
15. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer.
Nwogu CE; Groman A; Fahey D; Yendamuri S; Dexter E; Demmy TL; Miller A; Reid M
Ann Thorac Surg; 2012 May; 93(5):1614-9; discussion 1619-20. PubMed ID: 22440365
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio is a prognostic factor for non-small cell lung cancer.
Sun G; Xue L; Wang M; Zhao X
Oncotarget; 2015 Oct; 6(32):33912-8. PubMed ID: 26393881
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
Yang H; Mei T
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.
Li X; Lin H; Sun Y; Gong J; Feng H; Tu J
J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the number of lymph node metastases in esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
J Am Coll Surg; 2008 Feb; 206(2):239-46. PubMed ID: 18222375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
